RECURSION PHARMACEUTICALS, INC. (RXRX)

SEC filing

RECURSION PHARMACEUTICALS, INC.

RXRX · CIK 1601830

4 · Feb 19, 2026 · Gibson Christopher sold 40K shares at $3.46/share ($138.4K); converted 40K shares; reported 27.27K shares

Gibson Christopher sold 40K shares at $3.46/share ($138.4K); converted 40K shares; reported 27.27K shares

FORM 4

xslF345X05/wk-form4_1771547448.xmlSEC.gov

Graphics and non-inline formats (not embedded below).